Predictive Models Accelerate Nanodrug Development in Flow Systems

Developing nanotherapeutics is often a time-consuming and costly process due to the extreme sensitivity of nanoparticle properties to minor changes in manufacturing parameters. Factors such as concentration, flow rates, and mixing ratios can significantly impact the final size and polydispersity index (PDI) of nanoparticles, which are critical for clinical efficacy. Traditionally, this has necessitated extensive empirical testing and iterative optimization, lacking a strong predictive framework. Researchers have now proposed and validated a novel predictive modeling approach that incorporates shape constraints to improve the estimation of nanoparticle characteristics across various process conditions. This method leverages controlled microfluidic techniques to systematically prepare liposomes and lipid nanoparticles under different experimental settings. The shape-constrained model, which integrates both experimental data and expert knowledge, was successfully validated for pharmaceutical applications using only a small amount of empirical data. The findings indicate that this modeling framework can accurately predict nanoparticle size and dispersity, thereby substantially reducing the need for exhaustive experimental workflows and enabling a more rational and efficient development process for nanomedicine systems.